Transcranial magnetic stimulation (TMS) shows promise in diminishing the effects of early dementia and proves a safe and effective method for treating acute migraine and PPA.
A new small scale study reveals psilocybin appears to have a beneficial effect for chronic migraine sufferers.
2018 is almost upon us. We thought it would be a good time to take a look back at some of the most popular Neuroscience News stories of 2017.
A significant association has been discovered between migraine diagnoses and dementia in women.
Almost 1 in 5 people now use opioids to treat migraines. Researchers say a growing number of patients are using opioids to replace medications approved and specially designed to treat migraines, despite knowing the risks of opioid use.
Those with a genetic predisposition to clinical depression are more likely to exhibit physical symptoms including migraines, chronic pain, and fatigue, researchers report.
An immunotherapy that acts against an inflammatory molecule associated with migraines, has been shown to be successful in reducing the number of headaches people with chronic migraines suffer each month.
Researchers discover a link between the dynamics of seizures and spreading depression associated with migraine auras.
Four coagulation measures were associated with migraine with aura. These hemostatic factors may have a causal role in migraine with aura.
Researchers have identified 120 regions of the genome that are connected to migraine risk.
18% of new patients treated at two Los Angeles hospitals for multiple sclerosis were misdiagnosed with the autoimmune disease. The misdiagnosed patients were often treated unnecessarily with medications designed for MS. From their findings, researchers report the most common alternative diagnosis was migraine.
A new report examines the effect stress can have on our bodies and general health.
